BiotechTube
Home/Synedgen/Dr. Laura Saward
DL

Dr. Laura Saward

Chief Executive Officer

Synedgen

Therapeutic Areas

Infectious DiseaseWound HealingGastrointestinal

Synedgen Pipeline

DrugIndicationPhase
MIIST305GI Mucosal Injury / Gastrointestinal Acute Radiation Syndrome (GI-ARS)Pre-clinical

Leadership Team at Synedgen

DK
Dr. Kenton Gregory
Chief Medical Officer
View full Synedgen profile